Waddell & Reed Financial’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
BG
Waddell & Reed Financial's AGN Position: Q4 2018 in Review
Waddell & Reed Financial sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 65,000 shares — an estimated $12.4M sold.
Waddell & Reed Financial first reported a position in AGN in Q4 2014 and held it in 16 quarters. The position peaked at $1.42B in Q1 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.
- Waddell & Reed Financial reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
- Waddell & Reed Financial sold 65,000 Allergan plc shares in Q4 2018, an estimated $12.4M.
- Waddell & Reed Financial first reported a position in Allergan plc in Q4 2014 and held it in 16 quarters.
- Waddell & Reed Financial's Allergan plc position peaked at $1.42B in Q1 2015.
- 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.
Based on Waddell & Reed Financial's 13F filing for Q4 2018, filed 14 Feb 2019.